Perplexity of monocyte responses to C-reactive protein (CRP)

Thrombosis and Haemostasis

Volumn 99, Issue 3, 2008, Pages 461-462

  Filep, János G ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; MESSENGER RNA; OLIGONUCLEOTIDE;

APOPTOSIS; EDITORIAL; GENE EXPRESSION; HUMAN; MACROPHAGE; MICROARRAY ANALYSIS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL;

ANTIGENS, CD14; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX FACTORS; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

EID: 42249110893     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th08-02-0072     Document Type: Editorial

References (20)

1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
2. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004; 279: 48487-48490.
3. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6: 508-519.
4. Tsimikas S, Willerson JT, Ridker PM. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable plaque. J Am Coll Cardiol 2006; 47: C19-C31.
5. Danesh J, Wheeeler JG, Hirschfeld G, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-1397.
6. Scirica BM, Morrow DA, Verma S, et al. Is C-reactive protein an innocent bystander or proatherogenic culprit? Circulation 2006; 113: 2128-2151.
7. Paul A, Ko KW, Li L, et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004; 109: 647-655.
8. Schwedler SB, Amann K, Wernicke K, et al. Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation 2005; 112: 1016-1023.
9. Hirschfield GM, Gallimore JR, Kahan MC, et al. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 2005; 102: 8309-8314.
10. Kovacs A, Tornwall P, Nilsson R, et al. Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia. Proc Natl Acad Sci USA 2007; 104: 13768-13773.
11. Ballou CP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes. Cytokine 1992; 4: 361-368.
12. Xie L, Chang L, Guan Y , et al. CRP augments IL-8 secretion in human peripheral blood monocytes. J Cardiovasc Pharmacol 2005; 46: 690-696.
13. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
14. Devaraj S, Davis B, Simon SI, et al. CRP promotes monocyte-endothelial cell adhesion via Fcγ receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol 2006; 291: H1170-H1176.
15. Hanriot D, Bello G, Ropars A, et al. C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor α, on human monocytes. Thromb Haemost 2008; 99: 558-569.
16. Szalai AJ, Nataf S, Hu XZ, et al. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J Immunol 2002; 168: 5792-5797.
17. Scott J. The liver X receptor and atherosclerosis. N Engl J Med 2007; 357: 2195-2197.
18. Khreiss T, Jozsef L, Potempa LA, et al. Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res 2005; 97: 690-697.
19. Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003; 108: 1930-1932.
20. Sun H, Koike T, Ichikawa T, et al. C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol 2005; 167: 1139-1148.